Rôle du sacubitril-valsartan dans la prévention de la cardiotoxicité chez les patients à haut risque traités par anthracyclines - Résultats du SARAH Trial ...
Over the years, PAH-specific therapies have significantly enhanced patient survival. One such therapy is selexipag, an oral selective prostacyclin receptor agonist approved for PAH treatment (1). In ...
Hosted on MSN24y
Medications for Pulmonary Arterial HypertensionMedically reviewed by Lindsay Cook, PharmD Pulmonary hypertension (PH) can be challenging for healthcare professionals to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback